Co-Authors
This is a "connection" page, showing publications co-authored by Edmund Pribitkin and Madalina Tuluc.
Connection Strength
0.939
-
Topf MC, Wang ZX, Tuluc M, Pribitkin EA. TERT, HRAS, and EIF1AX mutations in a patient with follicular adenoma. Thyroid. 2018 Apr 19.
Score: 0.191
-
Topf MC, Wang ZX, Furlong K, Miller JL, Tuluc M, Pribitkin EA. EIF1AX Mutation in a Patient with Hürthle Cell Carcinoma. Endocr Pathol. 2018 Mar; 29(1):27-29.
Score: 0.189
-
Roy S, Aksamitiene E, Hota S, Zhang LH, Sciarrino J, Baker AL, Heffelfinger RN, Tuluc M, Hoek JB, Pribitkin EA. Aging effects on pedicled fasciocutaneous flap survival in rats. Head Neck. 2016 Apr; 38 Suppl 1:E1152-62.
Score: 0.159
-
Curry JM, Sprandio J, Cognetti D, Luginbuhl A, Bar-Ad V, Pribitkin E, Tuluc M. Tumor microenvironment in head and neck squamous cell carcinoma. Semin Oncol. 2014 Apr; 41(2):217-34.
Score: 0.143
-
Dilorenzo MM, Miller JL, Tuluc M, Wang ZX, Savarese VW, Pribitkin EA. False-Positive FNA Due to Highly Sensitive BRAF Assay. Endocr Pract. 2014 Jan-Feb; 20(1):e8-e10.
Score: 0.142
-
Curry JM, Tassone P, Cotzia P, Sprandio J, Luginbuhl A, Cognetti DM, Mollaee M, Domingo-Vidal M, Pribitkin EA, Keane WM, Zhan T, Birbe R, Tuluc M, Martinez-Outschoorn U. Multicompartment metabolism in papillary thyroid cancer. Laryngoscope. 2016 Oct; 126(10):2410-8.
Score: 0.041
-
Johnson JM, Lai SY, Cotzia P, Cognetti D, Luginbuhl A, Pribitkin EA, Zhan T, Mollaee M, Domingo-Vidal M, Chen Y, Campling B, Bar-Ad V, Birbe R, Tuluc M, Martinez Outschoorn U, Curry J. Mitochondrial Metabolism as a Treatment Target in Anaplastic Thyroid Cancer. Semin Oncol. 2015 Dec; 42(6):915-22.
Score: 0.040
-
Martinez-Outschoorn UE, Curry JM, Ko YH, Lin Z, Tuluc M, Cognetti D, Birbe RC, Pribitkin E, Bombonati A, Pestell RG, Howell A, Sotgia F, Lisanti MP. Oncogenes and inflammation rewire host energy metabolism in the tumor microenvironment: RAS and NFkB target stromal MCT4. Cell Cycle. 2013 Aug 15; 12(16):2580-97.
Score: 0.034